[ad_1]
Dublin, June 25, 2021 /PRNewswire/– “Global Antacids Market (2021-2026), by drug category, formulation, distribution channel, geography, and the impact of COVID-19 on Ansoff’s analysis” Report has been added to ResearchAndMarkets.com provide.
Antacids are usually over-the-counter (OTC) drugs used to neutralize stomach acid. The market has seen a wide range of antacids in various forms. Manufacturers in the antacid market are adopting different drug formulation technologies to support flavored chewable tablets to occupy the market.
Global antacid market estimate $5.5 billion Expected to reach in 2021 $6.56 billion By 2026, the compound annual growth rate will be 3.6%.
The increasing incidence of acid reflux, such as gastroesophageal reflux disease and unhealthy lifestyles, has promoted the growth of the market. However, the alternative market for antacids hinders the development of this market.
Market dynamics
driver
- Increased prevalence of gastroesophageal reflux disease (GERD)
- Growing elderly population
- Increased prevalence of heartburn
- Unhealthy lifestyle
constraint
- An increasing number of alternatives on the antacid market
opportunity
- Raise awareness of GERD
trend
- The rise of e-commerce has increased the demand for antacids
- Antacids melting in the mouth
Market segments covered
The global antacid market is further segmented according to drug category, formulation, distribution channel and geography.
Global antacid market, by drug category
- Introduction
- Proton pump inhibitor
- H2 antagonist
- Acid neutralizer
Global antacid market, by formula
- Introduction
- pill
- liquid
- powder
Global antacid market, by distribution channel
- Introduction
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
Global antacid market, by geographic location
- Introduction
- North America
- South America
- Europe
- Asia-Pacific
- middle East …
The full story on Benzinga.com
[ad_2]
Source link
